Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant
Clinical trial NCT04899349 · TERMINATED
Trial details
- NCT number
- NCT04899349
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-06
- Primary completion
- 2023-05-10
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.